Results 121 to 130 of about 9,672 (236)

Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients [PDF]

open access: gold, 2017
Onyema Ogbuagu   +4 more
openalex   +1 more source

Decreasing racial disparity with the combination of ledipasvir–sofosbuvir for the treatment of chronic hepatitis C

open access: yesHepatic Medicine: Evidence and Research, 2017
Paul H Naylor , Milton Mutchnick Department of Internal Medicine/Gastroenterology, Wayne State University School of Medicine, Detroit, MI, USA Abstract: African Americans (AA) in the US are twice as likely to be infected with hepatitis C virus (HCV)
Naylor PH, Mutchnick M
doaj  

Nuevos fármacos antivirales de acción directa en una población atendida por una unidad de enfermedades infecciosas. Estudio descriptivo [PDF]

open access: yes, 2017
La hepatitis C es una enfermedad infecciosa que afecta principalmente al hígado y está causada por un virus RNA de cadena positiva perteneciente a la familia Flaviviridae, género Hepacivirus, del que se conocen 7 genotipos, el último descrito ...
Gutiérrez Vélez, Rebeca
core  

Early sofosbuvir-ledipasvir treatment for acute HCV infection induced severe immune thrombocytopenia – a case report [PDF]

open access: gold, 2018
Vincent Alcazer   +4 more
openalex   +1 more source

All-Oral Combination of Ledipasvir, Vedroprevir, Tegobuvir, and Ribavirin in Treatment-Naïve Patients With Genotype 1 HCV Infection [PDF]

open access: bronze, 2014
David Wyles   +16 more
openalex   +1 more source

History and progress of antiviral drugs: from acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C [PDF]

open access: yes, 2015
The development of antiviral drugs is a very complex process. Currently, around 50 drugs have been approved for human use against viruses such as HSV, HIV-1, the cytomegalo virus, the influenza virus, HBV and HCV.
Barrera Saldaña, Hugo Alberto   +5 more
core  

Evolución de los pacientes infectados por el virus de la hepatitis C tratados con antivirales de acción directa en Álava. Durante el período 2015-2017. [PDF]

open access: yes, 2018
[ES] La infección por el virus de la hepatitis C (VHC) en la población general se caracteriza por una evolución crónica y, en general, benigna, tal como demuestran los estudios epidemiológicos prospectivos y retrospectivos.
Gil González, Cristina
core  

Home - About - Disclaimer - Privacy